What questions should be asked to reevaluate a patient after initiating nicotine replacement therapy?

Questions for Reevaluation After Starting Nicotine Replacement Therapy

Follow-up assessment should occur within 2-3 weeks of initiating NRT, focusing on smoking status, medication adherence, side effects, and relapse risk factors. 1

Timing of Follow-Up

• Initial follow-up: Within 2-3 weeks after starting NRT (can be extended to 3 weeks if coordinating with scheduled oncology appointments)
• Subsequent follow-up: At 12-week intervals during therapy
• Post-therapy: At 6 and 12 months after successful cessation 1

This timing is critical because nicotine withdrawal symptoms typically peak within 1-2 weeks of quitting, making early assessment essential for managing symptoms and preventing relapse 1.

Key Questions to Ask at Each Follow-Up

Smoking Status Assessment

• Are you currently smoking? (Complete abstinence vs. reduction vs. continued smoking)
• Have you had any smoking slips or lapses? (Brief episodes vs. full relapse)
• How many cigarettes per day are you smoking now? (Track reduction efforts) 1

Medication Adherence and Efficacy

• Are you using the NRT as prescribed? (Patch daily + short-acting NRT for cravings)
• How often are you using the short-acting NRT? (Frequency of craving episodes)
• Is the current dose controlling your cravings adequately? (May need dose adjustment to 35-42 mg patch if 21 mg ineffective) 1

Side Effects and Tolerability

For nicotine patches, specifically ask about:

• Skin reactions at application site
• Nausea or vomiting
• Sleep disturbances or vivid dreams
• Sweating or mood changes 2

For short-acting NRT (gum/lozenge/inhaler/spray), ask about:

• Jaw soreness (gum)
• Hiccups or burping (gum/lozenge)
• Mouth/throat irritation (inhaler/spray)
• Nasal irritation (spray) 2

Important caveat: NRT is well-tolerated and nicotine toxicity is rare, even with combination therapy. Blood nicotine levels from NRT are significantly lower than from smoking 1.

Relapse Risk Factor Assessment

Evaluate and document these specific risk factors: 1

• Frequent or intense cravings (may indicate need for dose increase)
• Elevated anxiety, stress, or depression (may require psychiatric referral)
• Living or working with smokers (environmental triggers)
• Time since quitting (less than 1 year = higher risk)
• Drug or alcohol use/abuse (marijuana, narcotics, stimulants - all increase relapse risk)
• Currently using cessation pharmacotherapy (vs. already discontinued)

Behavioral Support Engagement

• Are you attending counseling sessions? (Minimum 4 sessions in 12 weeks preferred)
• Are you using quitline or other support resources? 1

Decision Points Based on Responses

If Patient Remains Smoke-Free

• Reinforce success and importance of continued abstinence
• Continue current NRT regimen through minimum 12 weeks
• Consider extended therapy (6 months to 1 year) to prevent relapse
• Provide motivational strategies for continued abstinence 1

If Patient Has Brief Slips

• Encourage continued therapy - patients who don't quit immediately may quit later after withdrawal symptoms subside
• Do not automatically discontinue NRT during lapses
• Intensify behavioral support 1

If Reduction Efforts Stall or Abstinence Unlikely

• Consider dose adjustment (increase patch to 35-42 mg if on 21 mg)
• Switch to alternative pharmacotherapy (varenicline if on NRT, or vice versa)
• Intensify behavioral therapy with referral to specialty care if needed 1

If Significant Side Effects

• Adjust dose downward or change formulation
• Switch to alternative NRT form (e.g., from gum to lozenge)
• Consider switching to varenicline if NRT poorly tolerated 1

Common Pitfalls to Avoid

1. Don't wait too long for initial follow-up - The 2-3 week window is critical for catching problems early when withdrawal symptoms peak
2. Don't discontinue NRT during smoking lapses - Evidence supports continuing NRT even with return to smoking 3
3. Don't limit NRT duration arbitrarily - Some patients benefit from extended or even indefinite therapy to prevent relapse 2, 3
4. Don't ignore psychiatric comorbidities - Refer to specialists for management of anxiety, depression, or substance abuse 1
5. Don't forget to document - Record smoking status, risk factors, and management plans in the health record 1

Follow-Up Format

Follow-up can be conducted in-person or by phone - both are acceptable. In-person during scheduled clinical visits is preferred when possible, but phone contact is an effective alternative to reduce patient burden 1.